Dexamethasone The New COVID-19 Drug Will Be Used In Pakistan

Special Assistant to Prime Minister (SAPM) Zafar Mirza has revealed that a team of health experts is considering the use of dexamethasone which has been a recent breakthrough in the potential treatments of COVID-19. However, only serious patients will be treated with the drug.

In a Twitter statement, he said: “Positive results from the UK on use of Dexamethasone in critical patients welcomed by WHO as a 1st treatment to be shown to reduce mortality in patients with COVID-19 requiring Oxygen or ventilator support. Expert Committee in [Pakistan] to consider inclusion.”

So far, the drug is cheap and one of the oldest treatments and anti-inflammatory medicines (steroid). More so, it has multiple producers.

He clarified: “It is ONLY FOR critically ill COVID-19 patients ie those on oxygen and ventilators; the medicine MUST NOT be used by mild to moderate patients; self-medication is strictly prohibited and can be dangerous as the medicine has many side-effects.”

This treatment has been suggested by the medical experts in the UK who are calling the drug a “major breakthrough.”

“This is a result that shows that if patients who have COVID-19 and are on ventilators or are on oxygen are given dexamethasone, it will save lives, and it will do so at a remarkably low cost,” said Martin Landray, an Oxford University professor.

The post Dexamethasone The New COVID-19 Drug Will Be Used In Pakistan appeared first on Nation Bytes.